Noun
risankizumab (uncountable)
A monoclonal antibody used to treat psoriasis and similar conditions
Market research firm EvaluatePharma ranks AbbVie's pipeline as the second-best in the industry, with potential blockbuster drugs including risankizumab and upadacitinib likely on the way. Source: Internet
During his presentation Gordon noted that both studies met the primary endpoints, as well as all 15 ranked secondary endpoints, including nine that compared risankizumab to ustekinumab. Source: Internet